BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
FXYD4
,
T cell receptor signaling pathway
,
Inflammatory disorder
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CRKRS
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Basophil of peripheral blood
Natural killer cell of peripheral blood
Dendritic (plasmacytoid) cell
Liver
Leukocyte (polymorphonuclear) of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Varicella-zoster virus infection
Pyloric ulcer
Disease due to Arenavirus
Protozoan infection
Septicemia due to Enterococcus
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
fipexide
8-aminohexylamino cAMP
Wnt3a protein, mouse
Thiostrepton
GDNF protein, human
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
PDSS2
CDK12
PICALM
STK16
PICALM
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Transcription-associated cyclin-dependent kinase 12 (CDK12) as a potential target for cancer therapy…
CDK12 is a potential biomarker for diagnosis, prognosis and immunomodulation in pan-cancer.
The reversible inhibitor SR-4835 binds Cdk12/cyclin K in a noncanonical G-loop conformation.
Prognostic and clinicopathological value of CDK12 mutation in prostate cancer: a meta-analysis.
Current progress and novel strategies that target CDK12 for drug discovery.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Nivolumab and Veliparib in Treating Patients With Recurrent or Refractory Stage IV Solid Tumors That…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ